Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas

Piunti, Andrea, Hashizume, Rintaro, Morgan, Marc A, Bartom, Elizabeth T, Horbinski, Craig M, Marshall, Stacy A, Rendleman, Emily J, Ma, Quanhong +9 more·2017·Nature Medicine
DOI 10.1038/nm.4296

Cited by (458)

Items 301–400 of 458

  1. A homogeneous treatment for non-DIPG diffuse midline glioma
    Elisabetta Schiavello, Veronica Biassoni, Giovanna Gattuso, Marta Giorgia Podda, Stefano Chiaravalli, Francesco Barretta, Manila Antonelli, Loris De Cecco, Emilia Pecori, Lorenza Gandola et al. · 2022 · Tumori Journal
  2. Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma
    Ofir Griess, Noa Furth, Nofar Harpaz, Nicoletta Di Bernardo, Tomer‐Meir Salame, Bareket Dassa, Ioannis Karagiannidis, Yusuke Isshiki, Menachem Gross, Ari M. Melnick et al. · 2025 · PLoS Biology
  3. Genome-Wide Identification and Characterization of the BRD Family in Nile Tilapia (Oreochromis niloticus)
    Chunmei Xu, Miao Yu, Qingqing Zhang, Zhisheng Ma, Kang Du, Huiqin You, Jing Wei, Deshou Wang, Wenjing Tao · 2022 · Animals
  4. Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas
    Danielle Algranati, R. Oren, B. Dassa, Liat Fellus-Alyagor, A. Plotnikov, H. Barr, A. Harmelin, N. London, Guy Ron, Noa Furth et al. · 2024 · bioRxiv
  5. Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy
    Fei Xu, Xin Hua, Mengdi Wang · 2024 · Scientific Reports
  6. Convergent epigenetic regulation of glial plasticity in myelin repair and brain tumorigenesis: A focus on histone modifying enzymes
    Jiajia Wang, Qing Richard Lu · 2020 · Neurobiology of Disease
  7. Experimental murine models of brainstem gliomas
    Shuting Ni, Rujing Chen, Kaili Hu · 2021 · Drug Discovery Today
  8. The cancer epigenome: Non‐cell autonomous player in tumor immunity
    Shinichiro Kato, Yuka Maeda, Daisuke Sugiyama, Keisuke Watanabe, Hiroyoshi Nishikawa, Kunihiko Hinohara · 2022 · Cancer Science
  9. Diffuse intrinsic pontine glioma: Insights into oncogenesis and opportunities for targeted therapy
    Andrew P. Groves, Pratiti Bandopadhayay, Tabitha M. Cooney · 2023 · Pediatric Hematology Oncology Journal
  10. Dimethyl alpha-ketoglutarate inhibits proliferation in diffuse intrinsic pontine glioma by reprogramming epigenetic and transcriptional networks
    Kyubin Lee, Sohyeong Yun, Ji‐Su Park · 2023 · Biochemical and Biophysical Research Communications
  11. Histone H3 mutations and their impact on genome stability maintenance
    Lucas D. Caeiro, Ramiro E. Verdún, Lluís Morey · 2024 · Biochemical Society Transactions
  12. Invited Review: The role and contribution of transcriptional enhancers in brain cancer
    Amir Arabzade, Austin J. Stuckert, Kelsey C. Bertrand, Stephen C. Mack · 2020 · Neuropathology and Applied Neurobiology
  13. Diffuse Midline Glioma – Diffuse Intrinsic Pontine Glioma
    Mohammad Hassan A. Noureldine, Nir Shimony, George I. Jallo · 2020 · Springer eBooks
  14. Super elongation complex as a targetable dependency in diffuse midline glioma
    Nathan A. Dahl, Etienne P. Danis, Ilango Balakrishnan et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  15. CoBRA: Containerized Bioinformatics workflow for Reproducible ChIP/ATAC-seq Analysis - from differential peak calling to pathway analysis
    Xintao Qiu, Avery S. Feit, Ariel Feiglin et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  16. H3-K27M-Mutant Nucleosomes Interact with MLL1 to Shape the Glioma Epigenetic Landscape
    Noa Furth, Danielle Algranati, Bareket Dassa et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  17. The silent guardian: unraveling the roles of H3K9me3 in genome maintenance
    Zhiming Li, Zhiguo Zhang · 2024 · Genome Instability & Disease
  18. Novel modifiers of oncoprotein-mediated Polycomb inhibition in Drosophila melanogaster
    Samuel D. Krabbenhoft, Tyler E Masuda, Yadwinder Kaur, Truman J. Do, Siddhant U. Jain, Peter W. Lewis, Melissa M. Harrison · 2025 · Genetics
  19. Histone Lysine-to-Methionine Mutation as Anticancer Drug Target
    Jianhong Yang, Qiang Qiu, Lijuan Chen · 2020 · Advances in experimental medicine and biology
  20. Drosophila melanogaster: a fruitful model for oncohistones
    Amel Chaouch, Paul F. Lasko · 2021 · Fly
  21. Biological, Diagnostic, and Therapeutic Insights from (Epi)Genomic Profiling of Pediatric Brain Tumors
    Antonella De Cola, Amelia Foss, Richard J. Gilbertson, Manav Pathania · 2023 · Annual Review of Cancer Biology
  22. Rational combination platform trial design for children and young adults with diffuse midline glioma: A report from PNOC
    Sabine Mueller, Cassie Kline, Andrea T. Franson, Jasper van der Lugt, Michael D. Prados, Sebastian M. Waszak, Sabine L. A. Plasschaert, Annette M. Molinaro, Carl Johannes Koschmann, Javad Nazarian · 2023 · Neuro-Oncology
  23. Histone H3 Variants in the Multiverse of Cancer
    Iva Simeonova, Geneviève Almouzni · 2024 · Annual Review of Cancer Biology
  24. An E2 ubiquitin-conjugating enzyme links diubiquitinated H2B to H3K27M oncohistone function
    Alan L. Jiao, Erdem Sendinc, Barry M. Zee, Felice Wallner, Yang Shi · 2024 · Proceedings of the National Academy of Sciences
  25. Targeting the SP/KLF Transcriptional Regulatory Network Synergizes with HDAC Inhibition to Impede Progression of H3K27M Diffuse Intrinsic Pontine Glioma
    Yu Kong, Fan Wang, Renwei Jing, Qian Zhao, Xuejiao Lv, Yingying Zhao, Ye Yuan, Xianyou Xia, Yu Sun, Yujie Tong et al. · 2025 · Cancer Research
  26. Ultrasound Enhanced Anti-tumor Effect of Temozolomide in Glioblastoma Cells and Glioblastoma Mouse Model
    Jie Xue, Yuanyuan Wu, Na Liu · 2018 · Cellular and Molecular Bioengineering
  27. L’art de la guerre appliqué aux DIPG
    Quentin Bailleul, Andria Rakotomalala, Isabelle Ferry, Pierre Leblond, Samuel Meignan, Alessandro Furlan · 2021 · médecine/sciences
  28. Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma
    Evanthia Galanis, Patrick Yung Wen, John de Groot, Michael Weller · 2021 · Hematology/Oncology Clinics of North America
  29. Direct Readout of Multivalent Chromatin Reader-Nucleosome Interactions by Nucleosome Mass Spectrometry
    Alexander S. Lee, Nickolas P. Fisher, Matthew R. Marunde et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Histone H3 K27 alterations in central nervous system tumours: Challenges and alternative diagnostic approaches
    Nour Kurdi, Attila Mokánszki, Gábor Méhes, Judit Bedekovics · 2022 · Molecular and Cellular Probes
  31. New therapeutic targets for diffuse intrinsic pontine glioma
    Charlotte E. Ridler · 2017 · Nature Reviews Neurology
  32. Transcriptional and epigenetic regulatory mechanisms in glioblastoma stem cells
    Raul Bardini Bressan, Steven M. Pollard · 2020 · Elsevier eBooks
  33. Brainstem Tumors
    Peter A. Chiarelli, Jason K. Chu, Mark D. Krieger · 2020 · Springer eBooks
  34. Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy
    Michael Goldstein · 2023 · Oncotarget
  35. Probing the Function of Oncohistones Using Mutant Transgenes and Knock-In Mutations
    Dong Fang, Heping Wang, Zhiguo Zhang · 2018 · Methods in molecular biology
  36. Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones
    Jay F. Sarthy, Michael P. Meers, Derek H. Janssens et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Therapeutic reversal of prenatal pontine ID1 signaling in DIPG
    Viveka Nand Yadav, Micah K. Harris, Dana Messinger, Chase Thomas, Jessica R. Cummings, Tao Yang, Rinette W.L. Woo, Robert Siddaway, Martin Burkert, Stefanie Stallard et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Computer Designed PRC2 Inhibitor, EBdCas9, Reveals Functional TATA boxes in Distal Promoter Regions
    Shiri Levy, Logeshwaran Somasundaram, Infencia Xavier Raj, Diego Ic-Mex, Sven Schmidt, Ammar Alghadeer, Henrik Honkanen, R. David Hawkins, Julie Mathieu, Yuliang Wang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  39. BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
    Paul Huchedé, Swann Meyer, Clément Berthelot et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Catalytic-independent functions of INTAC in conferring sensitivity to BET inhibition
    Pengyu Fan, Xue-Ying Shang, Aixia Song, Shuo Chen, Run-Yuan Mao, Jiwei Chen, Zhenning Wang, Hai Zheng, Bolin Tao, Wei Xu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Clinicohistoradiological and surgical outcome in diffuse midline glioma
    Arvind Kumar Suman, Suchanda Bhattacharjee, Megha S. Uppin, Syed Tazeem Fathima · 2023 · Child s Nervous System
  42. Bibliometric and visualization analysis in the field of epigenetics and glioma (2009–2024)
    Yijun Zeng, Ge Tao, Yong Zeng, Jihong He, Hui Cao, Lushun Zhang · 2024 · Frontiers in Oncology
  43. Progress Toward Epigenetic Targeted Therapies for Childhood Cancer
    Athanasia Liapodimitri, Ashley R Tetens, Jordyn Craig-Schwartz, Kayleigh Lunsford, Kegan O. Skalitzky, Michael A. Koldobskiy · 2024 · Cancers
  44. Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
    Ilango Balakrishnan, Krishna P.C. Madhavan, Angela M. Pierce et al. · 2025 · Cancer Research
  45. What Child Neurologists Need to Know About Pediatric Glioma
    Subhi Talal Younes, Murali Chintagumpala · 2025 · Pediatric Neurology
  46. EZHIP in Pediatric Brain Tumors: From Epigenetic Mimicry to Therapeutic Vulnerabilities
    Tiziana Servidei, Serena Gentile, Alessandro Sgambato, Antonio Ruggiero · 2026 · International Journal of Molecular Sciences
  47. Deciphering the tumor microenvironment and role of immunotherapy in diffuse midline glioma: A scoping review
    Christian Kieran Ramsoomair, Felipe Sarmiento, Deryn Ramsoomair, Manav Daftari, Jiasen He, Benjamin Glazer, Michelle Monje, Danny Reinberg, Ashish H Shah · 2026 · Neuro-Oncology
  48. Biological Evaluation of a Novel Compound with Predicted EZH2 and EED Binding Against Human Malignant Melanoma Cells
    Sergei Gorbunov, Sotiris Kyriakou, Ioannis Anestopoulos, Shahzaib Khoso, Marcello Manfredi, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis · 2026 · International Journal of Molecular Sciences
  49. Interplay of Epigenetic Reprogramming, Mitochondrial Metabolism, and Dopamine Signalling Pathways Uncovers Metabolic Vulnerabilities in Diffuse Midline Glioma
    Han M. Shen, Yizhou Huang, Kristina M. Cook, Eric K.C. Hau · 2026 · Cancers
  50. Epigenetic Rewiring Underlies SMARCA4 -Dependent Maintenance of Progenitor State in Pediatric H3K27M Diffuse Midline Glioma
    Mary Clare Beytagh, William A. Weiss · 2022 · Cancer Discovery
  51. DPADM: a novel algorithm for detecting drug-pathway associations based on high-throughput transcriptional response to compounds
    Yishu Wang, Juan Qi, Dongmei Ai · 2022 · Briefings in Bioinformatics
  52. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience
    Jennifer K. Matsui, Pamela K. Allen, Haley Kopp Perlow, Jason Michael Johnson, Arnold C. Paulino, Mary Frances McAleer, Maryam Fouladi, David R. Grosshans, Amol Jitendra Ghia, Jing Li et al. · 2023 · Journal of Neuro-Oncology
  53. Therapeutic index of targeting select chromatin complexes in human cancer patients
    Yuan Gao, Christopher R. Vakoc · 2024 · Current Opinion in Genetics & Development
  54. Epigenetic dysregulation of high-grade gliomas: from heterogeneity to brain network modulation
    Kiyohito Murai, Nozomi Kobayashi, Wataru Tarumi, Yasukazu Nakahata, Kenta Masui · 2025 · Epigenomics
  55. Positron emission tomography imaging in diffuse intrinsic pontine glioma
    Norbert Galldiks, Carina Stegmayr, Antje Willuweit · 2017 · Annals of Translational Medicine
  56. The dark matter of diffuse intrinsic pontine gliomas: an update
    Jacques Grill, Marie-Anne Debily, Pascale Varlet, Alexandre Plessier, Ludivine Le Dret, Kévin Beccaria, Stéphanie Puget, David Castel · 2018 · Expert Opinion on Orphan Drugs
  57. Diffuse midline glioma, H3-K27M mutant: Awareness leads to identification
    Sadhana Tiwari, Ishita Pant, Sujata Chaturvedi · 2019 · Glioma
  58. Inhibitory protein puts a lid on an epigenetic marker
    Sergi Aranda, Luciano Di Croce · 2019 · Nature
  59. Update in Pediatric Neuro-Oncology
    Khatua, Soumen, Pillay Smiley, Natasha · 2019 · MDPI eBooks
  60. H3K27me3-mediated silencing of Wilms Tumor 1 supports the proliferation of brain tumor cells harboring the H3.3K27M mutation
    Fang Dong, Haiyun Gan, Liang Cheng C, Jeong‐Heon Lee, Hui Zhou, Jann Nagina Sarkaria, David J. Daniels, Zhiguo Zhang · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  61. PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
    Siddhant U. Jain, Truman J. Do, Peder J. Lund et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  62. HDAC4 controls senescence and aging by safeguarding the epigenetic identity and ensuring the genomic integrity
    Eros Di Giorgio, Harikrishnareddy Paluvai, Emiliano Dalla, Liliana Ranzino, Alessandra Renzini, Viviana Moresi, Valentina Cutano, Raffaella Picco, Claudio Brancolini · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Computer Designed PRC2 Inhibitor, EBdCas9, Reveals Functional TATA boxes in Distal Promoter Regions
    Shiri Levy · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  64. The H3.3K27M oncohistone antagonizes reprogramming in Drosophila
    Kami Ahmad, Steven Henikoff · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  65. BAP1 activity regulates PcG occupancy and global chromatin condensation counteracting diffuse PCGF3/5-dependent H2AK119ub1 deposition
    Eric Conway, Federico Rossi, Simone Tamburri, Eleonora Ponzo, Karin Johanna Ferrari, Marika Zanotti, Daniel Fernández-Pérez, Daria Manganaro, Simona Rodighiero, Diego Pasini · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug Response
    Chen He, Ke Xu, Xiaoyan Zhu, Paige Selvy Dunphy, Brian L. Gudenas, Wenwei Lin, Nathaniel R. Twarog, Laura D. Hover, Chang-Hyuk Kwon, Lawryn H. Kasper et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Developing Small Molecule Inhibitors of ALK2: A Serine/Threonine Kinase Implicated in Diffuse Intrinsic Pontine Glioma
    Deeba Ensan · 2020 · TSpace (University of Toronto)
  68. Epigenetics of T‐cell Lymphoma
    Henry Miles Prince, Jasmine M. Zain, Anas Younes, Sean J Whittaker, Owen A. O’Connor, Sean Harrop · 2021
  69. Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas
    Nofar Harpaz, Tamir Mittelman, Olga Beresh et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma
    Shejuan An, Jeannie Marie Camarillo, Tina C. Huang et al. · 2020 · Research Square
  71. Histone Tail Analysis Reveals H3K36me2 And H4K16ac As Epigenetic Signatures of Diffuse Intrinsic Pontine Glioma
    Shejuan An, Jeannie Marie Camarillo, Tina C. Huang et al. · 2020 · Research Square
  72. Isolation and Characterization of Immune Cells from the Tumor Microenvironment of Genetically Engineered Pediatric High Grade Glioma Models Using the Sleeping Beauty Transposon System v1
    María Belén Garcia-Fabiani, Andrea Comba, Padma Kadiyala, Santiago Haase, Felipe Javier Núñez, David Altshuler, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2020
  73. Single-molecule systems for detection and monitoring of plasma circulating nucleosomes and oncoproteins in Diffuse Midline Glioma
    Nir Erez, Noa Furth, Vadim Fedyuk et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Specific cPRC1 complexes are co-opted to mediate oncogenic gene repression in diffuse midline glioma
    Dáire Gannon, Eimear Lagan, Ademar Jesus Silva et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Targeting Diffuse Midline Glioma with a novel anti-CD99 Antibody
    Ilango Balakrishnan, Krishna P.C. Madhavan, Angela M. Pierce et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  76. H3F3A K27M Mutations Drives a Repressive Transcriptome by Modulating Chromatin Accessibility, Independent of H3K27me3 in Diffuse Midline Glioma
    Suraj Bhattarai, Faruck Lukmanul Hakkim, Charles A. Day · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma
    Ofir Griess, Noa Furth, Nofar Harpaz et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  78. SUZ12–Nucleic Acid Interactions Constrain PRC2 Activity to Maintain Targeted Gene Silencing Essential to Diffuse Midline Glioma
    Tyler J. Reich, Paul A. Clark, Audrey Baguette, Joanna K. Lempiäinen, Caterina Russo, Andrew Q. Rashoff, Truman J. Do, Benjamin Aaron Garcia, Claudia L. Kleinman, Nada Jabado et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Diffuse Midline Gliomas: Closer to a Cure?
    Reid Hoshide, Rahul Jandial · 2017 · Neurosurgery
  80. Local inhibition of PRC2 activity by H3.3K27M drives DNA replication defects through misregulation of the JNK pathway
    Kamila Delaney, Maude Strobino, Joanna M. Wenda · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Current Status and Future Prospects in the Field of Pediatric Tumors
    Akihide Kondo, Mario Suzuki, Junya Fujimura · 2019 · Japanese Journal of Neurosurgery
  82. Pharmacologic inhibition of lysine specific demethylase-1 (LSD1) as a therapeutic and immune-sensitization strategy in diffuse intrinsic pontine glioma (DIPG)
    Cavan P. Bailey, Megan M. Romero, Oren Josh Becher, Michelle Monje, Dean Anthony Lee, Linghua Wang, Joya Chandra · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Pediatric glioblastoma - unlike normal cells - are sensitive to the combination of vorinostat and olaparib and to its downstream effector - phosphorylated eIF2α
    Karin Eytan, Ziv Versano, Moshe Leitner, Shoshana Paglin, Amos Toren, Michal Yalon · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  84. The H3K36me2 writer-reader dependency in H3K27M-DIPG
    Jia-Ray Yu, Gary LeRoy, Devin Bready · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Computer Designed PRC2 Inhibitor, EBdCas9, Reveals Functional TATA Boxes in Distal Promoter Regions
    Shiri Levy, Logeshwaran Somasundaram, Infencia Xavier Raj, Diego Ic-Mex, Sven Schmidt, Ammar Alghadeer, Henrik Honkanen, R. David Hawkins, Julie Mathieu, Yuliang Wang et al. · 2020 · SSRN Electronic Journal
  86. Genomic Instability and the Oncohistone H3K27M Drive Gliomagenesis in a Murine Model
    Lee J. Pribyl · 2020
  87. A chemical strategy toward novel brain-penetrant EZH2 inhibitors
    Rui Liang, Daisuke Tomita, Yusuke Sasaki et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Epigenetic Targets in the Treatment of cancer
    Giovanni Codacci-Pisanelli · 2017 · Novel Approaches in Drug Designing & Development
  89. The Polycomb Protein Bmi1 is a Key Effector of the H3.3 K27m Oncohistone
    Wencong Cui, Marios Xydous, Alexander Haschke et al. · 2021 · SSRN Electronic Journal
  90. Delphes: le trésor de Siphnos
    Lerco Elisa · 2014 · Publications Docs-en-stock.com
  91. Incorporation of a histone mutant with H3K56 site substitution perturbs the replication machinery in mouse embryonic stem cells
    Xuan Kang, Xiaomei Yang, Guo Xiaobo, Yabin Li, Chenxin Yang, Huimin Wei, Jian-Feng Chang · 2022 · Journal of Molecular Cell Biology
  92. The diverse landscape of histone-mutant pediatric high-grade gliomas
    Evan Lubanszky, Cynthia E Hawkins · 2022 · Glioma
  93. Faculty Opinions recommendation of H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis.
    Jason T. Huse · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  94. Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma
    Shejuan An, Jeannie Marie Camarillo, Tina C. Huang et al. · 2020 · Research Square
  95. Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
    Matthew J Pun, Drew W. Pratt, Patricia R. Nano et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  96. EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
    Pierre Romero, Laia Richart, Setareh Aflaki et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Data from Loss of H3K27 Trimethylation Promotes Radiotherapy Resistance in Medulloblastoma and Induces an Actionable Vulnerability to BET Inhibition
    Nishanth Gabriel, Kumaresh Balaji, Kay Jayachandran · 2023
  98. Data from Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors
    Yukitomo Ishi, Yongzhan Zhang, Ali Zhang, Takahiro Sasaki, Andrea Piunti, Amreena Suri, Jun Watanabe, Kouki Abe, Xingyao He, Hiroaki Katagi et al. · 2023
  99. Effects of histone 3.3K27M-mutation on CREB binding protein (CBP/p300)- and bromodomain and extra terminal domain (BET) protein- mediated gene regulation in diffuse intrinsic pontine gliomas (DIPG)
    Klaudia Kubiak · 2023
  100. Clinicohistoradiological and Surgical Outcome in Diffuse Midline Glioma
    Arvind Kumar, Suchanda Bhattacharjee, Megha S. Uppin · 2023 · Research Square